|
SEC63 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.747400E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.880000E-01 |
| Normal-vs-Stage2 |
6.354400E-01 |
| Normal-vs-Stage3 |
6.261600E-02 |
| Normal-vs-Stage4 |
4.044400E-02 |
| Stage1-vs-Stage2 |
6.108600E-01 |
| Stage1-vs-Stage3 |
2.641700E-02 |
| Stage1-vs-Stage4 |
2.119600E-02 |
| Stage2-vs-Stage3 |
4.942400E-01 |
| Stage2-vs-Stage4 |
3.927800E-01 |
| Stage3-vs-Stage4 |
7.808600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.501400E-01 |
| Normal-vs-AfricanAmerican |
8.608100E-02 |
| Normal-vs-Asian |
6.484000E-01 |
| Caucasian-vs-AfricanAmerican |
3.016600E-01 |
| Caucasian-vs-Asian |
9.230800E-01 |
| AfricanAmerican-vs-Asian |
7.258000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.132820E-01 |
| Normal-vs-Female |
9.921600E-01 |
| Male-vs-Female |
7.200300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.494800E-01 |
| Normal-vs-Age(41-60Yrs) |
4.680400E-01 |
| Normal-vs-Age(61-80Yrs) |
2.817400E-01 |
| Normal-vs-Age(81-100Yrs) |
4.621400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.576600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.239200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.404400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.152800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.516800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.274600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.420400E-02 |
| Normal-vs-Grade 2 |
4.840000E-01 |
| Normal-vs-Grade 3 |
4.013600E-02 |
| Normal-vs-Grade 4 |
1.005680E-02 |
| Grade 1-vs-Grade 2 |
3.523000E-01 |
| Grade 1-vs-Grade 3 |
1.148230E-02 |
| Grade 1-vs-Grade 4 |
5.417600E-03 |
| Grade 2-vs-Grade 3 |
1.003850E-03 |
| Grade 2-vs-Grade 4 |
7.556600E-04 |
| Grade 3-vs-Grade 4 |
3.193800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.764200E-02 |
| Normal-vs-ccB subtype |
7.938500E-03 |
| ccA subtype-vs-ccB subtype |
9.68479999974292E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.778600E-01 |
| Normal-vs-N1 |
3.707700E-02 |
| N0-vs-N1 |
1.531160E-01 |
|
|
